Bio­Marin strikes co­op­er­a­tion deal with ac­tivist in­vestor El­liott, sets up re­view com­mit­tee and adds board mem­bers

More than a month af­ter ac­tivist in­vestor El­liott In­vest­ment Man­age­ment bought a $1 bil­lion stake in Bio­Marin, the two have reached a deal to co­op­er­ate and share in­for­ma­tion as they seek to boost the biotech’s per­for­mance.

Bio­Marin is al­so set­ting up a strate­gic op­er­at­ing re­view com­mit­tee on the board to re­view its busi­ness, strat­e­gy and op­er­a­tions, fi­nan­cial and cap­i­tal al­lo­ca­tion pri­or­i­ties as well as long-term plan­ning.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER